Work

ITGA2 Mediates the Resistance of Hepatocellular Carcinoma to Lenvatinib by Activating the AKT/FOXO3A Signaling Pathway

Year: 2025

Type: article

Abstract: The global incidence of primary liver cancer ranks sixth among malignant tumors, while its mortality rate ranks third and is the second leading cause of cancer-related deaths in China [...].

Source: Cancers

DOI: 10.3390/cancers17172846

Authors: Kai Gong, Bin Xu, Lian Gong, Ming Zhong, Chun Han, Yuechuan Liu, Zeli Yin, Xiangnan Liang, Qiuxiang Wang, Genhua Ye, Binwen Sun, Liming Wang

Institutions: Dalian Medical University, Second Affiliated Hospital of Dalian Medical University, Sun Yat-sen University, The Seventh Affiliated Hospital of Sun Yat-sen University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,499

Funder: National Natural Science Foundation of China

Awards: G2649478242, G3816075671, G4520324241, G6514999033, G73892866, G7516454037, G8226262669, G8884671577

OpenAlex ID: W4413833555

FWCI: 1.49

Cites: 49

Cited by: 3

Related to: 10